SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'CPZ'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_A_9CRA501_1 (CYTOCHROME P450 2C8) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 11 | ARG A 98ILE A 114ALA A 298THR A 302VAL A 367PRO A 368 | HEM A 500 (-2.9A)HEM A 500 (-4.0A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.76A | 2nnhA-3tk3A:52.7 | 2nnhA-3tk3A:55.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_A_9CRA501_1 (CYTOCHROME P450 2C8) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 11 | ARG A 98ALA A 298THR A 302VAL A 367PRO A 368 | HEM A 501 (-2.7A)HEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 ( 4.4A)None | 0.77A | 2nnhA-5e0eA:52.2 | 2nnhA-5e0eA:52.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNH_B_9CRB501_1 (CYTOCHROME P450 2C8) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 9 | ARG A 98ILE A 114THR A 302VAL A 367PRO A 368 | HEM A 500 (-2.9A)HEM A 500 (-4.0A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.69A | 2nnhB-3tk3A:45.9 | 2nnhB-3tk3A:55.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2NNJ_A_225A501_1 (CYTOCHROME P450 2C8) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | ILE A 114ALA A 298THR A 302VAL A 367PRO A 368 | HEM A 500 (-4.0A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.75A | 2nnjA-3tk3A:53.6 | 2nnjA-3tk3A:55.46 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_A_4PZA501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 3 / 3 | ALA A 298THR A 302CYH A 436 | CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 (-2.3A) | 0.61A | 3e4eA-3tk3A:48.5 | 3e4eA-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3E4E_B_4PZB501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 3 / 3 | ALA A 298THR A 302CYH A 436 | CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 (-2.3A) | 0.55A | 3e4eB-3tk3A:54.3 | 3e4eB-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 9 / 11 | ILE A 114ILE A 209PHE A 297ALA A 298THR A 302ILE A 363VAL A 367VAL A 477GLY A 478 | HEM A 500 (-4.0A)NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A)HEM A 500 ( 4.3A)NoneNone | 0.64A | 3kw4A-3tk3A:60.2 | 3kw4A-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 9 / 11 | ILE A 114ILE A 209SER A 210PHE A 297ALA A 298THR A 302VAL A 367VAL A 477GLY A 478 | HEM A 500 (-4.0A)NoneNoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)NoneNone | 0.72A | 3kw4A-3tk3A:60.2 | 3kw4A-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 7 / 11 | ILE A 209PHE A 297ALA A 298GLU A 301THR A 302ILE A 363VAL A 367 | NoneNoneHEM A 501 ( 3.1A)NoneCPZ A 502 ( 4.0A)HEM A 501 (-4.1A)HEM A 501 ( 4.4A) | 0.88A | 3kw4A-5e0eA:54.6 | 3kw4A-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KW4_A_TICA600_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 7 / 11 | ILE A 209SER A 210PHE A 297ALA A 298GLU A 301THR A 302VAL A 367 | NoneNoneNoneHEM A 501 ( 3.1A)NoneCPZ A 502 ( 4.0A)HEM A 501 ( 4.4A) | 1.03A | 3kw4A-5e0eA:54.6 | 3kw4A-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 8 / 10 | VAL A 104PHE A 108ILE A 209ALA A 298THR A 302ILE A 363VAL A 367VAL A 477 | NoneNoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A)HEM A 500 ( 4.3A)None | 0.53A | 3me6A-3tk3A:62.9 | 3me6A-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 10 | VAL A 104PHE A 108ILE A 209PHE A 297ALA A 298THR A 302 | NoneNoneNoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.05A | 3me6A-3tk3A:62.9 | 3me6A-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 10 | ILE A 209PHE A 297ALA A 298THR A 302ILE A 363VAL A 367 | NoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A)HEM A 501 ( 4.4A) | 1.08A | 3me6A-5e0eA:53.7 | 3me6A-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_A_CGEA501_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 7 / 10 | VAL A 104PHE A 108ILE A 209ALA A 298THR A 302ILE A 363VAL A 367 | NoneNoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A)HEM A 501 ( 4.4A) | 1.00A | 3me6A-5e0eA:53.7 | 3me6A-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_B_CGEB501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 8 | PHE A 108ILE A 209ALA A 298THR A 302VAL A 367VAL A 477 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.46A | 3me6B-3tk3A:62.9 | 3me6B-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_C_CGEC501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 7 / 9 | VAL A 104PHE A 108ILE A 209ALA A 298THR A 302VAL A 367VAL A 477 | NoneNoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.56A | 3me6C-3tk3A:62.9 | 3me6C-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_C_CGEC501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 9 | VAL A 104PHE A 108ILE A 209PHE A 297ALA A 298THR A 302 | NoneNoneNoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.06A | 3me6C-3tk3A:62.9 | 3me6C-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_C_CGEC501_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 9 | VAL A 104PHE A 108ILE A 209THR A 302VAL A 367 | NoneNoneNoneCPZ A 502 ( 4.0A)HEM A 501 ( 4.4A) | 0.80A | 3me6C-5e0eA:53.6 | 3me6C-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 9 | PHE A 108ILE A 209PHE A 297ALA A 298THR A 302 | NoneNoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.24A | 3me6D-3tk3A:62.9 | 3me6D-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 7 / 9 | VAL A 104PHE A 108ILE A 209ALA A 298THR A 302VAL A 367VAL A 477 | NoneNoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.38A | 3me6D-3tk3A:62.9 | 3me6D-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 9 | ILE A 209PHE A 297ALA A 298THR A 302VAL A 367 | NoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 ( 4.4A) | 1.10A | 3me6D-5e0eA:53.8 | 3me6D-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ME6_D_CGED501_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 9 | VAL A 104PHE A 108ILE A 209ALA A 298THR A 302VAL A 367 | NoneNoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 ( 4.4A) | 0.82A | 3me6D-5e0eA:53.8 | 3me6D-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_A_9PLA501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 115ALA A 298THR A 302ILE A 363 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 0.48A | 3t3qA-3tk3A:56.8 | 3t3qA-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_A_9PLA501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 10 | PHE A 108VAL A 114PHE A 115ALA A 298THR A 302ILE A 363 | NoneHEM A 501 (-3.5A)NoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 0.83A | 3t3qA-5e0eA:51.7 | 3t3qA-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_A_9PLA501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 10 | PHE A 115PHE A 297ALA A 298THR A 302ILE A 363 | NoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 1.10A | 3t3qA-5e0eA:51.7 | 3t3qA-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_B_9PLB501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 115ALA A 298THR A 302ILE A 363 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 0.57A | 3t3qB-3tk3A:56.8 | 3t3qB-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_B_9PLB501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 297ALA A 298THR A 302ILE A 363 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 1.03A | 3t3qB-3tk3A:56.8 | 3t3qB-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_B_9PLB501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 10 | PHE A 108VAL A 114PHE A 115ALA A 298THR A 302ILE A 363 | NoneHEM A 501 (-3.5A)NoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 0.90A | 3t3qB-5e0eA:51.7 | 3t3qB-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_B_9PLB501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 10 | PHE A 115PHE A 297ALA A 298THR A 302ILE A 363 | NoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 1.20A | 3t3qB-5e0eA:51.7 | 3t3qB-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 115ALA A 298THR A 302ILE A 363 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 0.55A | 3t3qC-3tk3A:56.7 | 3t3qC-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 297ALA A 298THR A 302ILE A 363 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 1.06A | 3t3qC-3tk3A:56.7 | 3t3qC-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 10 | PHE A 108VAL A 114PHE A 115ALA A 298THR A 302ILE A 363 | NoneHEM A 501 (-3.5A)NoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 0.90A | 3t3qC-5e0eA:51.7 | 3t3qC-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_C_9PLC501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 10 | PHE A 115PHE A 297ALA A 298THR A 302ILE A 363 | NoneNoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 1.18A | 3t3qC-5e0eA:51.7 | 3t3qC-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_D_9PLD501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 115ALA A 298THR A 302ILE A 363 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 0.59A | 3t3qD-3tk3A:56.9 | 3t3qD-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_D_9PLD501_1 (CYTOCHROME P450 2A6) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 10 | PHE A 108PHE A 297ALA A 298THR A 302ILE A 363 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A) | 1.03A | 3t3qD-3tk3A:56.9 | 3t3qD-3tk3A:56.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Q_D_9PLD501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 10 | PHE A 108VAL A 114PHE A 115ALA A 298THR A 302ILE A 363 | NoneHEM A 501 (-3.5A)NoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A) | 0.93A | 3t3qD-5e0eA:51.8 | 3t3qD-5e0eA:56.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3R_A_9PLA501_1 (CYTOCHROME P450 2A6) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 11 | PHE A 108VAL A 114PHE A 115GLY A 299THR A 302 | NoneHEM A 501 (-3.5A)NoneHEM A 501 (-3.5A)CPZ A 502 ( 4.0A) | 0.93A | 3t3rA-5e0eA:51.5 | 3t3rA-5e0eA:55.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_B_9PLB1_1 (CYTOCHROME P450 2A13) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 6 | PHE A 115PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.19A | 3t3sB-3tk3A:55.9 | 3t3sB-3tk3A:56.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_D_9PLD1_1 (CYTOCHROME P450 2A13) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 8 | PHE A 108PHE A 115ALA A 298THR A 302 | NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.65A | 3t3sD-3tk3A:55.6 | 3t3sD-3tk3A:56.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3S_F_9PLF1_1 (CYTOCHROME P450 2A13) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 8 | PHE A 108PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.97A | 3t3sF-3tk3A:53.7 | 3t3sF-3tk3A:56.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Z_A_9PLA501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 6 | PHE A 115PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.61A | 3t3zA-3tk3A:53.9 | 3t3zA-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Z_B_9PLB501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 6 | PHE A 115PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.61A | 3t3zB-3tk3A:53.9 | 3t3zB-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Z_C_9PLC501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 5 | PHE A 115PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.56A | 3t3zC-3tk3A:54.0 | 3t3zC-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3T3Z_D_9PLD501_1 (CYTOCHROME P450 2E1) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 6 | PHE A 115PHE A 297ALA A 298THR A 302 | NoneCPZ A 501 (-4.3A)CPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 0.60A | 3t3zD-3tk3A:53.9 | 3t3zD-3tk3A:49.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 7 / 11 | ILE A 101ILE A 114ILE A 209ALA A 298THR A 302VAL A 367PRO A 368 | CPZ A 501 (-4.2A)HEM A 500 (-4.0A)NoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A)None | 0.94A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 11 | ILE A 101ILE A 114PHE A 115ILE A 209ALA A 298THR A 302 | CPZ A 501 (-4.2A)HEM A 500 (-4.0A)NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.12A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 11 | ILE A 101ILE A 114PHE A 206ILE A 209ALA A 298THR A 302 | CPZ A 501 (-4.2A)HEM A 500 (-4.0A)NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.16A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 11 | ILE A 114PHE A 108ILE A 209ALA A 298THR A 302VAL A 367 | HEM A 500 (-4.0A)NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 4.3A) | 1.16A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 6 / 11 | ILE A 114PHE A 108PHE A 206ILE A 209ALA A 298THR A 302 | HEM A 500 (-4.0A)NoneNoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A) | 1.39A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 7 / 11 | ILE A 101PHE A 108PHE A 206ILE A 209ALA A 298GLU A 301THR A 302 | CPZ A 502 (-4.7A)NoneNoneNoneHEM A 501 ( 3.1A)NoneCPZ A 502 ( 4.0A) | 1.24A | 3tmzA-5e0eA:55.8 | 3tmzA-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 8 / 11 | ILE A 101PHE A 206ILE A 209ALA A 298GLU A 301THR A 302VAL A 367PRO A 368 | CPZ A 502 (-4.7A)NoneNoneHEM A 501 ( 3.1A)NoneCPZ A 502 ( 4.0A)HEM A 501 ( 4.4A)None | 0.87A | 3tmzA-5e0eA:55.8 | 3tmzA-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA503_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 11 | PHE A 115ILE A 209ALA A 298GLU A 301THR A 302VAL A 367 | NoneNoneHEM A 501 ( 3.1A)NoneCPZ A 502 ( 4.0A)HEM A 501 ( 4.4A) | 0.88A | 3tmzA-5e0eA:55.8 | 3tmzA-5e0eA:79.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TMZ_A_06XA504_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 9 | LEU A 70ILE A 101ILE A 209GLN A 215GLU A 387 | NoneCPZ A 501 (-4.2A)NoneNoneNone | 1.07A | 3tmzA-3tk3A:56.8 | 3tmzA-3tk3A:99.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FGL_D_CLQD303_1 (RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE[QUINONE]) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 4 / 6 | GLY A 478GLY A 476GLU A 301ILE A 209 | NoneNoneCPZ A 501 (-3.8A)None | 0.97A | 4fglD-3tk3A:undetectable | 4fglD-3tk3A:18.12 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4H1N_A_CGEA505_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 8 / 11 | ILE A 101ILE A 114ILE A 209LEU A 238ALA A 298THR A 302ILE A 363VAL A 367 | CPZ A 501 (-4.2A)HEM A 500 (-4.0A)NoneNoneCPZ A 501 (-3.5A)CPZ A 501 ( 3.7A)HEM A 500 ( 3.9A)HEM A 500 ( 4.3A) | 0.52A | 4h1nA-3tk3A:59.7 | 4h1nA-3tk3A:99.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4H1N_A_CGEA505_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 6 / 11 | ILE A 101LEU A 238ALA A 298THR A 302ILE A 363VAL A 367 | CPZ A 502 (-4.7A)NoneHEM A 501 ( 3.1A)CPZ A 502 ( 4.0A)HEM A 501 (-4.1A)HEM A 501 ( 4.4A) | 0.66A | 4h1nA-5e0eA:53.7 | 4h1nA-5e0eA:79.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JLT_A_8PRA505_1 (CYTOCHROME P450 2B4) |
3tk3 | CYTOCHROME P450 2B4 (Oryctolaguscuniculus) | 5 / 8 | ILE A 114GLU A 218ALA A 298VAL A 367PRO A 368 | HEM A 500 (-4.0A)NoneCPZ A 501 (-3.5A)HEM A 500 ( 4.3A)None | 0.64A | 4jltA-3tk3A:60.7 | 4jltA-3tk3A:99.79 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4JLT_A_8PRA505_1 (CYTOCHROME P450 2B4) |
5e0e | CYTOCHROME P450FAMILY 2 SUBFAMILY B (Neotomalepida) | 5 / 8 | ILE A 101GLU A 218ALA A 298VAL A 367PRO A 368 | CPZ A 502 (-4.7A)NoneHEM A 501 ( 3.1A)HEM A 501 ( 4.4A)None | 1.09A | 4jltA-5e0eA:54.7 | 4jltA-5e0eA:79.87 |